![Zhi Yang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Zhi Yang
Fondateur chez
Shanghai Bioveda Investment Management Consulting Co. Ltd.
Profil
Zhi Yang founded BVCF Investment Consulting (Shanghai) Ltd. He occupies the position of Chairman at MicuRx Pharmaceuticals, Inc. and Founding Partner at Shanghai Bioveda Investment Management Consulting Co. Ltd., Chairman & Managing Partner at BVCF Investment Consulting (Shanghai) Ltd. (a subsidiary of Shanghai Bioveda Investment Management Consulting Co. Ltd.).
Zhi Yang is also on the board of Nexchem Pharmaceutical Co., Ltd.
He received a doctorate and a graduate degree from Harvard University and an undergraduate degree from Wuhan University.
Postes actifs de Zhi Yang
| Sociétés | Poste | Début |
|---|---|---|
Shanghai Bioveda Investment Management Consulting Co. Ltd.
 Shanghai Bioveda Investment Management Consulting Co. Ltd. Investment ManagersFinance BioVeda China is an active manager which invests in innovative Chinese companies exclusively in the life science and healthcare sectors, including pharmaceuticals, biotech, medtech, healthcare services and industrial biotech. They invest in companies from series A to mezzanine stage, invest only in early-stage which have breakthrough platform technology and huge market potential. The firm seeks to invest in companies with a dominant market position, rapid growth potential, a strong management team, proprietary technologies, significant competitive advantages, a business model with clear exit strategy or survivability and sale, merger or listing potential within three to five years. BioVeda partners with their investee companies, providing them with strategic assistance to realize growth. | Fondateur | 01/01/2005 |
Nexchem Pharmaceutical Co., Ltd.
 Nexchem Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Produces active pharmaceutical ingredients for global markets | Directeur/Membre du Conseil | 21/02/2011 |
BVCF Investment Consulting (Shanghai) Ltd.
 BVCF Investment Consulting (Shanghai) Ltd. Investment ManagersFinance Provides investment advice | Fondateur | 01/01/2005 |
MicuRx Pharmaceuticals, Inc.
 MicuRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops antibiotics to combat drug resistant bacterial infections | Président | 22/06/2018 |
Anciens postes connus de Zhi Yang
| Sociétés | Poste | Fin |
|---|---|---|
Jaguar Animal Health, Inc.
 Jaguar Animal Health, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes first-in-class gastrointestinal products for companion and production animals | Directeur/Membre du Conseil | - |
| JAGUAR HEALTH, INC. | Directeur/Membre du Conseil | - |
NOD Pharmaceuticals, Inc.
 NOD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Directeur/Membre du Conseil | - |
Formation de Zhi Yang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
17
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Shanghai Bioveda Investment Management Consulting Co. Ltd.
Shanghai Bioveda Investment Management Consulting Co. Ltd. Investment ManagersFinance BioVeda China is an active manager which invests in innovative Chinese companies exclusively in the life science and healthcare sectors, including pharmaceuticals, biotech, medtech, healthcare services and industrial biotech. They invest in companies from series A to mezzanine stage, invest only in early-stage which have breakthrough platform technology and huge market potential. The firm seeks to invest in companies with a dominant market position, rapid growth potential, a strong management team, proprietary technologies, significant competitive advantages, a business model with clear exit strategy or survivability and sale, merger or listing potential within three to five years. BioVeda partners with their investee companies, providing them with strategic assistance to realize growth. | Finance |
Jaguar Animal Health, Inc.
Jaguar Animal Health, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes first-in-class gastrointestinal products for companion and production animals | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wuhan University
 Wuhan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MicuRx Pharmaceuticals, Inc.
MicuRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops antibiotics to combat drug resistant bacterial infections | Health Technology |
NOD Pharmaceuticals, Inc.
NOD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Nexchem Pharmaceutical Co., Ltd.
Nexchem Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Produces active pharmaceutical ingredients for global markets | Health Technology |
BVCF Investment Consulting (Shanghai) Ltd.
BVCF Investment Consulting (Shanghai) Ltd. Investment ManagersFinance Provides investment advice | Finance |
Jaguar Health, Inc.
 Jaguar Health, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
